These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 33606360)

  • 41. The effects of testosterone replacement therapy in men with age-dependent hypogonadism on body composition, and serum levels of leptin, adiponectin, and C-reactive protein.
    Dudek P; Kozakowski J; Zgliczyński W
    Endokrynol Pol; 2020; 71(5):382-387. PubMed ID: 32797473
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Symptom report and treatment experience of hypogonadal men with and without type 2 diabetes in a United States health plan.
    Shortridge EF; Polzer P; Donga P; Wade RL
    Int J Clin Pract; 2015 Jul; 69(7):783-90. PubMed ID: 25854747
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Determination of factors affecting medication adherence in type 2 diabetes mellitus patients using a nationwide claim-based database in Japan.
    Horii T; Momo K; Yasu T; Kabeya Y; Atsuda K
    PLoS One; 2019; 14(10):e0223431. PubMed ID: 31593574
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Testosterone undecanoate improves sexual function in men with type 2 diabetes and severe hypogonadism: results from a 30-week randomized placebo-controlled study.
    Hackett G; Cole N; Saghir A; Jones P; Strange RC; Ramachandran S
    BJU Int; 2016 Nov; 118(5):804-813. PubMed ID: 27124889
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Adherence to oral diabetes medications and glycemic control during and following breast cancer treatment.
    Calip GS; Hubbard RA; Stergachis A; Malone KE; Gralow JR; Boudreau DM
    Pharmacoepidemiol Drug Saf; 2015 Jan; 24(1):75-85. PubMed ID: 24923811
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of continuous long-term testosterone therapy (TTh) on anthropometric, endocrine and metabolic parameters for up to 10 years in 115 hypogonadal elderly men: real-life experience from an observational registry study.
    Yassin AA; Nettleship J; Almehmadi Y; Salman M; Saad F
    Andrologia; 2016 Sep; 48(7):793-9. PubMed ID: 26762680
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Testosterone replacement therapy in hypogonadal men: assessing benefits, risks, and best practices.
    Miner M; Canty DJ; Shabsigh R
    Postgrad Med; 2008 Sep; 120(3):130-53. PubMed ID: 18824832
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidence and Risk Factors of Hypogonadism in Male Patients With Latent Autoimmune Diabetes and Classic Type 2 Diabetes.
    Cai M; Cui R; Yang P; Gao J; Cheng X; Sheng C; Li H; Sheng H; Qu S; Zhang M
    Front Endocrinol (Lausanne); 2021; 12():675525. PubMed ID: 34135863
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Testosterone Increases the Expression and Phosphorylation of AMP Kinase α in Men With Hypogonadism and Type 2 Diabetes.
    Ghanim H; Dhindsa S; Batra M; Green K; Abuaysheh S; Kuhadiya ND; Makdissi A; Chaudhuri A; Sandhu S; Dandona P
    J Clin Endocrinol Metab; 2020 Apr; 105(4):1169-75. PubMed ID: 31858126
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Testosterone replacement therapy improves insulin resistance, glycaemic control, visceral adiposity and hypercholesterolaemia in hypogonadal men with type 2 diabetes.
    Kapoor D; Goodwin E; Channer KS; Jones TH
    Eur J Endocrinol; 2006 Jun; 154(6):899-906. PubMed ID: 16728551
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The response to testosterone undecanoate in men with type 2 diabetes is dependent on achieving threshold serum levels (the BLAST study).
    Hackett G; Cole N; Bhartia M; Kennedy D; Raju J; Wilkinson P; Saghir A;
    Int J Clin Pract; 2014 Feb; 68(2):203-15. PubMed ID: 24355040
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hypogonadism and its treatment following ischaemic stroke in men with type 2 diabetes mellitus.
    Morgunov LY; Denisova IA; Rozhkova TI; Stakhovskaya LV; Skvortsova VI
    Aging Male; 2020 Mar; 23(1):71-80. PubMed ID: 30064273
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of testosterone replacement therapy on metabolic syndrome among Japanese hypogonadal men: A subanalysis of a prospective randomised controlled trial (EARTH study).
    Shigehara K; Konaka H; Nohara T; Izumi K; Kitagawa Y; Kadono Y; Iwamoto T; Koh E; Mizokami A; Namiki M
    Andrologia; 2018 Feb; 50(1):. PubMed ID: 28497534
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Testosterone replacement in congenital hypogonadotropic hypogonadism maintains bone density but has only limited osteoanabolic effects.
    Antonio L; Caerels S; Jardi F; Delaunay E; Vanderschueren D
    Andrology; 2019 May; 7(3):302-306. PubMed ID: 30851011
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Therapy of the "aging male"].
    Diemer T; Hauck EW; Rohde V; Weidner W
    Urologe A; 2005 Oct; 44(10):1173-8. PubMed ID: 16151757
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-related androgen deficiency and type 2 diabetes.
    Ryan GJ; Jobe LJ
    J Pharm Pract; 2011 Jun; 24(3):316-22. PubMed ID: 21676855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Correlation Between Testosterone and Metabolic Index in Male Patients with Type 2 Diabetes Mellitus].
    Cao W; Zheng RD; Fan YF; Liu C
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2018 Mar; 49(2):235-238. PubMed ID: 29737067
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MYTHS AND CONTROVERSIES IN HYPOGONADISM TREATMENT OF AGING MALES.
    Ungureanu MC; Costache II; Preda C; Mogoş V; Vulpoi C; Leuştean L
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):325-33. PubMed ID: 26204632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of testosterone undecanoate on cardiovascular risk factors and atherosclerosis in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 24-month, randomized, double-blind, placebo-controlled study.
    Aversa A; Bruzziches R; Francomano D; Rosano G; Isidori AM; Lenzi A; Spera G
    J Sex Med; 2010 Oct; 7(10):3495-503. PubMed ID: 20646185
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Testosterone replacement in men.
    Beg S; Al-Khoury L; Cunningham GR
    Curr Opin Endocrinol Diabetes Obes; 2008 Aug; 15(4):364-70. PubMed ID: 18594278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.